Browsing: CD44v5

Research

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11

By NewsCancerAugust 21, 20260

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options, and the development of chemoresistance…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

County-Level Medical Debt Tied to Later-Stage Cancer Diagnosis, Worse Survival

Managing Diarrhea and Optimizing Dose Reductions With NALIRIFOX

Discussing Advances in the Stereotactic Management of Brain Metastases

Browsing: CD44v5

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11

County-Level Medical Debt Tied to Later-Stage Cancer Diagnosis, Worse Survival

Managing Diarrhea and Optimizing Dose Reductions With NALIRIFOX

Discussing Advances in the Stereotactic Management of Brain Metastases

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11

County-Level Medical Debt Tied to Later-Stage Cancer Diagnosis, Worse Survival

Managing Diarrhea and Optimizing Dose Reductions With NALIRIFOX

Discussing Advances in the Stereotactic Management of Brain Metastases

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11

Latest Post

County-Level Medical Debt Tied to Later-Stage Cancer Diagnosis, Worse Survival

Managing Diarrhea and Optimizing Dose Reductions With NALIRIFOX

Discussing Advances in the Stereotactic Management of Brain Metastases

Subscribe to Updates

What's Hot

Browsing: CD44v5